Q4 2024 · 13F-HR
Integral Health Asset Management, LLCholdings as filed
Filed 2025-02-14 · accession 0001172661-25-000938
$1.17B
Reported value
83
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 457669307 | INSM | INSMED INC | $107.0M | 9.12% | 1,550,000 | Common | SOLE |
| 88033G407 | THC | TENET HEALTHCARE CORP | $50.5M | 4.30% | 400,000 | Common | SOLE |
| 101137107 | BSX | BOSTON SCIENTIFIC CORP | $49.1M | 4.19% | 550,000 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $48.6M | 4.15% | 1,150,000 | Common | SOLE |
| 23282W605 | CYTK | CYTOKINETICS INC | $47.0M | 4.01% | 1,000,000 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $34.5M | 2.94% | 500,000 | CALL | SOLE |
| 15135B101 | CNC | CENTENE CORP DEL | $30.3M | 2.58% | 500,000 | Common | SOLE |
| 14149Y108 | CAH | CARDINAL HEALTH INC | $29.6M | 2.52% | 250,000 | Common | SOLE |
| 532457108 | LLY | ELI LILLY & CO | $29.3M | 2.50% | 38,000 | Common | SOLE |
| 29261A100 | EHC | ENCOMPASS HEALTH CORP | $27.7M | 2.36% | 300,000 | Common | SOLE |
| 76155X100 | RVMD | REVOLUTION MEDICINES INC | $24.1M | 2.05% | 550,000 | Common | SOLE |
| 09627Y109 | 2655787D | BLUEPRINT MEDICINES CORP | $24.0M | 2.04% | 275,000 | Common | SOLE |
| 126650100 | CVS | CVS HEALTH CORP | $22.4M | 1.91% | 500,000 | Common | SOLE |
| 64125C109 | NBIX | NEUROCRINE BIOSCIENCES INC | $21.8M | 1.86% | 160,000 | Common | SOLE |
| 46120E602 | ISRG | INTUITIVE SURGICAL INC | $20.9M | 1.78% | 40,000 | Common | SOLE |
| 58155Q103 | MCK | MCKESSON CORP | $19.9M | 1.70% | 35,000 | Common | SOLE |
| 58933Y105 | MRK | MERCK & CO INC | $19.9M | 1.70% | 200,000 | Common | SOLE |
| 110122108 | BMY | BRISTOL-MYERS SQUIBB CO | $19.8M | 1.69% | 350,000 | Common | SOLE |
| 74834L100 | DGX | QUEST DIAGNOSTICS INC | $19.6M | 1.67% | 130,000 | Common | SOLE |
| N90064101 | QURE | UNIQURE NV | $19.4M | 1.66% | 1,100,000 | Common | SOLE |
| 87650L103 | TARS | TARSUS PHARMACEUTICALS INC | $19.4M | 1.65% | 350,000 | Common | SOLE |
| 457730109 | INSP | INSPIRE MED SYS INC | $18.5M | 1.58% | 100,000 | Common | SOLE |
| 375558103 | GILD | GILEAD SCIENCES INC | $18.5M | 1.57% | 200,000 | Common | SOLE |
| 45332Y109 | NARIUSD | INARI MED INC | $17.9M | 1.52% | 350,000 | Common | SOLE |
| 80706P103 | SRRK | SCHOLAR ROCK HLDG CORP | $16.2M | 1.38% | 375,000 | Common | SOLE |
| 10950A106 | BTSG | BRIGHTSPRING HEALTH SVCS INC | $16.2M | 1.38% | 950,000 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $15.3M | 1.31% | 300,000 | Common | SOLE |
| 046353108 | AZNN | ASTRAZENECA PLC | $14.7M | 1.26% | 225,000 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $14.7M | 1.25% | 550,000 | Common | SOLE |
| 471871202 | JSPR | JASPER THERAPEUTICS INC | $13.9M | 1.18% | 650,000 | Common | SOLE |
| 358029106 | FMS | FRESENIUS MEDICAL CARE AG | $13.6M | 1.16% | 600,000 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $13.4M | 1.14% | 420,000 | Common | SOLE |
| G5960L103 | MDT | MEDTRONIC PLC | $12.0M | 1.02% | 150,000 | Common | SOLE |
| 00404A109 | ACHC | ACADIA HEALTHCARE COMPANY IN | $11.9M | 1.01% | 300,000 | Common | SOLE |
| 252131107 | DXCM | DEXCOM INC | $11.7M | 0.99% | 150,000 | Common | SOLE |
| 09075V102 | BNTX | BIONTECH SE | $11.4M | 0.97% | 100,000 | Common | SOLE |
| 941848103 | WAT | WATERS CORP | $11.1M | 0.95% | 30,000 | Common | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $11.0M | 0.94% | 500,000 | Common | SOLE |
| 61559X104 | MLTX | MOONLAKE IMMUNOTHERAPEUTICS | $10.8M | 0.92% | 200,000 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $10.8M | 0.92% | 875,000 | Common | SOLE |
| 47103J105 | JANX | JANUX THERAPEUTICS INC | $10.7M | 0.91% | 200,000 | Common | SOLE |
| 02043Q107 | ALNY | ALNYLAM PHARMACEUTICALS INC | $10.6M | 0.90% | 45,000 | Common | SOLE |
| 444859102 | HUM | HUMANA INC | $10.1M | 0.86% | 40,000 | Common | SOLE |
| 687793109 | OSCR | OSCAR HEALTH INC | $9.4M | 0.80% | 700,000 | Common | SOLE |
| 216648501 | COO | COOPER COS INC | $9.2M | 0.78% | 100,000 | Common | SOLE |
| 501147102 | KRYS | KRYSTAL BIOTECH INC | $8.6M | 0.73% | 55,000 | Common | SOLE |
| 30063P105 | EXK | EXACT SCIENCES CORP | $8.4M | 0.72% | 150,000 | Common | SOLE |
| 76243J105 | RYTM | RHYTHM PHARMACEUTICALS INC | $8.4M | 0.72% | 150,000 | Common | SOLE |
| 28036F105 | EWTX | EDGEWISE THERAPEUTICS INC | $8.0M | 0.68% | 300,000 | CALL | SOLE |
| 282559103 | ETNBGBP | 89BIO INC | $7.8M | 0.67% | 1,000,000 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $7.7M | 0.65% | 100,000 | Common | SOLE |
| 74365U107 | TARA | PROTARA THERAPEUTICS INC | $7.4M | 0.63% | 1,400,000 | Common | SOLE |
| 492327101 | KROS | KEROS THERAPEUTICS INC | $7.1M | 0.61% | 450,000 | Common | SOLE |
| 75901B107 | RGNX | REGENXBIO INC | $7.0M | 0.59% | 900,000 | Common | SOLE |
| 219798105 | QDEL | QUIDELORTHO CORP | $6.7M | 0.57% | 150,000 | Common | SOLE |
| 14888U101 | CPRX | CATALYST PHARMACEUTICALS INC | $6.3M | 0.53% | 300,000 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $6.0M | 0.51% | 150,000 | Common | SOLE |
| 116794108 | BRKR | BRUKER CORP | $5.9M | 0.50% | 100,000 | Common | SOLE |
| 759916109 | RGEN | REPLIGEN CORP | $5.8M | 0.49% | 40,000 | Common | SOLE |
| 01625V104 | ALHC | ALIGNMENT HEALTHCARE INC | $5.6M | 0.48% | 500,000 | Common | SOLE |
| 452327109 | ILMN | ILLUMINA INC | $5.3M | 0.46% | 40,000 | Common | SOLE |
| 45784P101 | PODD | INSULET CORP | $5.2M | 0.45% | 20,000 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $5.2M | 0.44% | 275,000 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $4.7M | 0.40% | 250,000 | Common | SOLE |
| 931427108 | WFC | WALGREENS BOOTS ALLIANCE INC | $4.7M | 0.40% | 500,000 | Common | SOLE |
| 88322Q108 | TGTX | TG THERAPEUTICS INC | $4.5M | 0.38% | 150,000 | Common | SOLE |
| 729139105 | PLRX | PLIANT THERAPEUTICS INC | $4.0M | 0.34% | 300,000 | Common | SOLE |
| 85205L107 | SWTXUSD | SPRINGWORKS THERAPEUTICS INC | $3.6M | 0.31% | 100,000 | Common | SOLE |
| 26818M108 | DYN | DYNE THERAPEUTICS INC | $3.5M | 0.30% | 150,000 | Common | SOLE |
| 589492107 | MREO | MEREO BIOPHARMA GROUP PLC | $3.5M | 0.30% | 1,000,000 | Common | SOLE |
| 799566104 | SANA | SANA BIOTECHNOLOGY INC | $3.3M | 0.28% | 2,000,000 | Common | SOLE |
| 98943L107 | ZNTL | ZENTALIS PHARMACEUTICALS INC | $3.2M | 0.27% | 1,050,000 | Common | SOLE |
| 880881107 | 430 | TERNS PHARMACEUTICALS INC | $2.5M | 0.21% | 450,000 | Common | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $2.5M | 0.21% | 500,000 | Common | SOLE |
| 852312305 | STAA | STAAR SURGICAL CO | $2.4M | 0.21% | 100,000 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $1.7M | 0.15% | 100,000 | Common | SOLE |
| 82686Q101 | SLN | SILENCE THERAPEUTICS PLC | $1.4M | 0.12% | 200,000 | Common | SOLE |
| 002120202 | ATYR | ATYR PHARMA INC | $1.4M | 0.12% | 375,000 | Common | SOLE |
| 501976104 | KYTX | KYVERNA THERAPEUTICS INC | $1.3M | 0.11% | 350,000 | Common | SOLE |
| 02157Q109 | ANRO | ALTO NEUROSCIENCE INC | $1.3M | 0.11% | 300,000 | Common | SOLE |
| 12674W109 | CABA | CABALETTA BIO INC | $1.1M | 0.10% | 500,000 | Common | SOLE |
| 31189P102 | FATE | FATE THERAPEUTICS INC | $990,000 | 0.08% | 600,000 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $756,000 | 0.06% | 200,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.